Epperly Melissa B,: insider trades.
Epperly Melissa B, reported 8 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($806K), across 1 company.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Epperly Melissa B,
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Roivant Sciences Ltd. (ROIV) | Director | 8 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-16 | Roivant Sciences Ltd. | A | 5,054 | $0 | 14,954 | Form 4 |
| 2026-09-15 | Roivant Sciences Ltd. | S | 4,338 | $39.65 | 10,500 | Form 4 |
| 2026-09-15 | Roivant Sciences Ltd. | S | 600 | $40.38 | 9,900 | Form 4 |
| 2026-09-10 | Roivant Sciences Ltd. | F | 2,179 | $40.94 | 14,838 | Form 4 |
| 2026-07-17 | Roivant Sciences Ltd. | A | 543 | $0 | 17,017 | Form 4 |
| 2026-06-29 | Roivant Sciences Ltd. | M | 17,750 | $4.46 | 34,224 | Form 4 |
| 2026-06-29 | Roivant Sciences Ltd. | S | 2,748 | $34.71 | 16,474 | Form 4 |
| 2026-06-29 | Roivant Sciences Ltd. | S | 15,002 | $34.32 | 19,222 | Form 4 |
Questions
What stock did Epperly Melissa B, buy or sell?
Epperly Melissa B, reported 8 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($806K), across 1 company.
Is Epperly Melissa B, the same person as other filers with this name?
This page covers SEC CIK 1807359 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/epperly-melissa-b-1807359.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.